Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Dillehay

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2013
Advocating for appropriate and adequate reimbursementGary Dillehay
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2019
The Martinique PrinciplesSukhjeet Ahuja, Anca M Avram, Gary Dillehay, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2007
Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancerSuneel N Nagda, Najeeb Mohideen, Simon S Lo, et al.
Journal of Nuclear Medicine Technology|August 20, 2011
Euro-American discussion document on entry-level and advanced practice in nuclear medicineKristen Waterstram-Rich, Peter Hogg, Giorgio Testanera, et al.
Journal of Nuclear Medicine Technology|March 29, 2012
SNM practice guideline for parathyroid scintigraphy 4.0Bennett S Greenspan, Gary Dillehay, Charles Intenzo, et al.
Journal of Nuclear Medicine Technology|November 10, 2011
The SNM practice guideline for somatostatin receptor scintigraphy 2.0Helena R Balon, Tracy L Y Brown, Stanley J Goldsmith, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin LymphomaNitika Paudel, Derek Schulze, Ryan D Gentzler, et al.
Blood|September 29, 2020
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphomaPamela B Allen, Hatice Savas, Andrew M Evens, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2019
Controversies, Consensus, and Collaboration in the Use of <sup>131</sup>I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid AssociationR Michael Tuttle, Sukhjeet Ahuja, Anca M Avram, et al.
Blood Advances|September 9, 2022
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphomaPamela B Allen, Xinyan Lu, Qing Chen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2013
Advocating for appropriate and adequate reimbursementGary Dillehay
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2019
The Martinique PrinciplesSukhjeet Ahuja, Anca M Avram, Gary Dillehay, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2007
Long-term follow-up of 111In-capromab pendetide (ProstaScint) scan as pretreatment assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancerSuneel N Nagda, Najeeb Mohideen, Simon S Lo, et al.
Journal of Nuclear Medicine Technology|August 20, 2011
Euro-American discussion document on entry-level and advanced practice in nuclear medicineKristen Waterstram-Rich, Peter Hogg, Giorgio Testanera, et al.
Journal of Nuclear Medicine Technology|March 29, 2012
SNM practice guideline for parathyroid scintigraphy 4.0Bennett S Greenspan, Gary Dillehay, Charles Intenzo, et al.
Journal of Nuclear Medicine Technology|November 10, 2011
The SNM practice guideline for somatostatin receptor scintigraphy 2.0Helena R Balon, Tracy L Y Brown, Stanley J Goldsmith, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2019
Patterns of Failure and Survival Outcomes after Total Lymphoid Irradiation and High-Dose Chemotherapy with Autologous Stem Cell Transplantation for Relapsed or Refractory Classical Hodgkin LymphomaNitika Paudel, Derek Schulze, Ryan D Gentzler, et al.
Blood|September 29, 2020
Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphomaPamela B Allen, Hatice Savas, Andrew M Evens, et al.
Thyroid : Official Journal of the American Thyroid Association|March 23, 2019
Controversies, Consensus, and Collaboration in the Use of <sup>131</sup>I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid AssociationR Michael Tuttle, Sukhjeet Ahuja, Anca M Avram, et al.
Blood Advances|September 9, 2022
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphomaPamela B Allen, Xinyan Lu, Qing Chen, et al.
Pageof 2